Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.

Publication

Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.

Journal Paper/Review - Jun 24, 2024

Moschouri Eleni, Salemme Gloria, Baserga Adriana, Cerny Andreas, Deibel Ansgar, Muellhaupt Beat, Meier Marie-Anne, Bernsmeier Christine, Ongaro Marie, Negro Francesco, Grosjean Marielle, Clerc Olivier F, Künzler-Heule Patrizia, Semela David, Hobi Gabriel, Stickel Felix, Mathieu Adeline, Mdawar-Bailly Elise, Faouzi Mohamed, Moradpour Darius, Fraga Montserrat

Citation

Moschouri E, Salemme G, Baserga A, Cerny A, Deibel A, Muellhaupt B, Meier M, Bernsmeier C, Ongaro M, Negro F, Grosjean M, Clerc O, Künzler-Heule P, Semela D, Hobi G, Stickel F, Mathieu A, Mdawar-Bailly E, Faouzi M, Moradpour D, Fraga M. Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis. Swiss Med Wkly 2024; 154:3698.

Type

Journal Paper/Review (English)

Journal

Swiss Med Wkly 2024; 154

Publication Date

Jun 24, 2024

Issn Electronic

1424-3997

Pages

3698

Brief description/objective

Direct-acting antivirals (DAAs) have revolutionised the management of chronic hepatitis C. We analysed the use of different generations of DAAs over time in Switzerland and investigated factors predictive of treatment failure.